Drugs affecting adrenergic function

Diane S. Aschenbrenner, Samantha J. Venable

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

• Regulation of physiologic processes in the autonomic nervous system (ANS) is managed by oppositional or complementary stimulation by the sympathetic (adrenergic) and parasympathetic (cholinergic) nervous systems. • To effect an action, a neurotransmitter needs to bind with an appropriate receptor site on the effector organ or tissue. • The primary neurotransmitter of the sympathetic nervous system (SNS) is norepinephrine (NE). Additionally, epinephrine and dopamine stimulate adrenergic receptors. • The SNS, commonly referred to as the fi ght-or-fl ight system, increases cardiovascular and respiratory function, increases metabolism, diverts blood to muscles, and decreases GI activity. • SNS receptors with pharmacological relevance are subdivided into alpha-1, alpha-2, beta-1, and beta-2 subtypes. Alpha-1, beta-1, and beta-2 receptors are located on the post-synaptic side of the synapse, while alpha-2 receptors are located on the pre-synaptic side of the synapse. Stimulation of alpha-2 receptors acts as a negative feedback and shuts off the fl ow of NE, stopping sympathetic stimulation. • Adrenergic agonists stimulate the adrenergic receptors, whereas adrenergic antagonists block adrenergic receptors within the SNS, preventing endogenous neurotransmitters from attaching to the receptor. There are multiple terms for these categories of drugs. • Alpha-1 agonists, such as phenylephrine, stimulate alpha-1 receptors directly. They are most commonly used as nasal decongestants and in ophthalmology to achieve mydriasis. They may also be used as vasopressors to treat vascular failure and related shock. • Alpha-2 agonists such as clonidine shut off the sympathetic release of NE and sympathetic stimulation. They are used in the treatment of substance abuse to prevent withdrawal symptoms and have a minor use in the treatment of hypertension. • Nonselective adrenergic agonists, such as epinephrine, are used to treat anaphylactic shock, asthma, hemorrhage, and ventricular fi brillation. The nonselective activity stimulates all four adrenergic subtypes. • Dopamine, a vasopressor, is used to correct the hemodynamic imbalances present in shock. Dopamine is a naturally occurring catecholamine and a precursor to norepinephrine. It stimulates alpha and beta receptors directly and indirectly (by releasing the stored epinephrine). It also has dopaminergic effects, including increased renal perfusion, increased cardiac output, increased or decreased peripheral resistance (depending on the dose), and increased blood pressure. • Drugs that are relatively selective for beta-2 stimulation are used to treat asthma. • Fenoldopam, a dopamine-1 agonist, is used in the management of acute hypertension for rapid reduction of blood pressure. • Alpha-1 antagonists, such as prazosin, cause vasodilation and are used to treat hypertension and benign prostatic hyperplasia (BPH). • Beta-blockers, such as metoprolol, are relatively selective for beta-1 receptors in the heart; in larger doses they also have effects on beta-2 receptors. They are used to treat hypertension, angina, controlled chronic heart failure, cardiac arrhythmias, hyperthyroidism, and migraine headache.

Original languageEnglish (US)
Title of host publicationDrug Therapy in Nursing
PublisherWolters Kluwer Health Adis (ESP)
Pages161-194
Number of pages34
ISBN (Electronic)9781469819174
ISBN (Print)9781451187663
StatePublished - Nov 7 2012

Fingerprint

Sympathetic Nervous System
Adrenergic Agents
Norepinephrine
Adrenergic Receptors
Epinephrine
Hypertension
Neurotransmitter Agents
Dopamine
Adrenergic Agonists
Synapses
Shock
Asthma
Fenoldopam
Parasympathetic Nervous System
Nasal Decongestants
Blood Pressure
Mydriasis
Dopamine Agents
Substance Withdrawal Syndrome
Metoprolol

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Aschenbrenner, D. S., & Venable, S. J. (2012). Drugs affecting adrenergic function. In Drug Therapy in Nursing (pp. 161-194). Wolters Kluwer Health Adis (ESP).

Drugs affecting adrenergic function. / Aschenbrenner, Diane S.; Venable, Samantha J.

Drug Therapy in Nursing. Wolters Kluwer Health Adis (ESP), 2012. p. 161-194.

Research output: Chapter in Book/Report/Conference proceedingChapter

Aschenbrenner, DS & Venable, SJ 2012, Drugs affecting adrenergic function. in Drug Therapy in Nursing. Wolters Kluwer Health Adis (ESP), pp. 161-194.
Aschenbrenner DS, Venable SJ. Drugs affecting adrenergic function. In Drug Therapy in Nursing. Wolters Kluwer Health Adis (ESP). 2012. p. 161-194
Aschenbrenner, Diane S. ; Venable, Samantha J. / Drugs affecting adrenergic function. Drug Therapy in Nursing. Wolters Kluwer Health Adis (ESP), 2012. pp. 161-194
@inbook{e94dd4683b3747baae32d8ce9e9084b3,
title = "Drugs affecting adrenergic function",
abstract = "• Regulation of physiologic processes in the autonomic nervous system (ANS) is managed by oppositional or complementary stimulation by the sympathetic (adrenergic) and parasympathetic (cholinergic) nervous systems. • To effect an action, a neurotransmitter needs to bind with an appropriate receptor site on the effector organ or tissue. • The primary neurotransmitter of the sympathetic nervous system (SNS) is norepinephrine (NE). Additionally, epinephrine and dopamine stimulate adrenergic receptors. • The SNS, commonly referred to as the fi ght-or-fl ight system, increases cardiovascular and respiratory function, increases metabolism, diverts blood to muscles, and decreases GI activity. • SNS receptors with pharmacological relevance are subdivided into alpha-1, alpha-2, beta-1, and beta-2 subtypes. Alpha-1, beta-1, and beta-2 receptors are located on the post-synaptic side of the synapse, while alpha-2 receptors are located on the pre-synaptic side of the synapse. Stimulation of alpha-2 receptors acts as a negative feedback and shuts off the fl ow of NE, stopping sympathetic stimulation. • Adrenergic agonists stimulate the adrenergic receptors, whereas adrenergic antagonists block adrenergic receptors within the SNS, preventing endogenous neurotransmitters from attaching to the receptor. There are multiple terms for these categories of drugs. • Alpha-1 agonists, such as phenylephrine, stimulate alpha-1 receptors directly. They are most commonly used as nasal decongestants and in ophthalmology to achieve mydriasis. They may also be used as vasopressors to treat vascular failure and related shock. • Alpha-2 agonists such as clonidine shut off the sympathetic release of NE and sympathetic stimulation. They are used in the treatment of substance abuse to prevent withdrawal symptoms and have a minor use in the treatment of hypertension. • Nonselective adrenergic agonists, such as epinephrine, are used to treat anaphylactic shock, asthma, hemorrhage, and ventricular fi brillation. The nonselective activity stimulates all four adrenergic subtypes. • Dopamine, a vasopressor, is used to correct the hemodynamic imbalances present in shock. Dopamine is a naturally occurring catecholamine and a precursor to norepinephrine. It stimulates alpha and beta receptors directly and indirectly (by releasing the stored epinephrine). It also has dopaminergic effects, including increased renal perfusion, increased cardiac output, increased or decreased peripheral resistance (depending on the dose), and increased blood pressure. • Drugs that are relatively selective for beta-2 stimulation are used to treat asthma. • Fenoldopam, a dopamine-1 agonist, is used in the management of acute hypertension for rapid reduction of blood pressure. • Alpha-1 antagonists, such as prazosin, cause vasodilation and are used to treat hypertension and benign prostatic hyperplasia (BPH). • Beta-blockers, such as metoprolol, are relatively selective for beta-1 receptors in the heart; in larger doses they also have effects on beta-2 receptors. They are used to treat hypertension, angina, controlled chronic heart failure, cardiac arrhythmias, hyperthyroidism, and migraine headache.",
author = "Aschenbrenner, {Diane S.} and Venable, {Samantha J.}",
year = "2012",
month = "11",
day = "7",
language = "English (US)",
isbn = "9781451187663",
pages = "161--194",
booktitle = "Drug Therapy in Nursing",
publisher = "Wolters Kluwer Health Adis (ESP)",

}

TY - CHAP

T1 - Drugs affecting adrenergic function

AU - Aschenbrenner, Diane S.

AU - Venable, Samantha J.

PY - 2012/11/7

Y1 - 2012/11/7

N2 - • Regulation of physiologic processes in the autonomic nervous system (ANS) is managed by oppositional or complementary stimulation by the sympathetic (adrenergic) and parasympathetic (cholinergic) nervous systems. • To effect an action, a neurotransmitter needs to bind with an appropriate receptor site on the effector organ or tissue. • The primary neurotransmitter of the sympathetic nervous system (SNS) is norepinephrine (NE). Additionally, epinephrine and dopamine stimulate adrenergic receptors. • The SNS, commonly referred to as the fi ght-or-fl ight system, increases cardiovascular and respiratory function, increases metabolism, diverts blood to muscles, and decreases GI activity. • SNS receptors with pharmacological relevance are subdivided into alpha-1, alpha-2, beta-1, and beta-2 subtypes. Alpha-1, beta-1, and beta-2 receptors are located on the post-synaptic side of the synapse, while alpha-2 receptors are located on the pre-synaptic side of the synapse. Stimulation of alpha-2 receptors acts as a negative feedback and shuts off the fl ow of NE, stopping sympathetic stimulation. • Adrenergic agonists stimulate the adrenergic receptors, whereas adrenergic antagonists block adrenergic receptors within the SNS, preventing endogenous neurotransmitters from attaching to the receptor. There are multiple terms for these categories of drugs. • Alpha-1 agonists, such as phenylephrine, stimulate alpha-1 receptors directly. They are most commonly used as nasal decongestants and in ophthalmology to achieve mydriasis. They may also be used as vasopressors to treat vascular failure and related shock. • Alpha-2 agonists such as clonidine shut off the sympathetic release of NE and sympathetic stimulation. They are used in the treatment of substance abuse to prevent withdrawal symptoms and have a minor use in the treatment of hypertension. • Nonselective adrenergic agonists, such as epinephrine, are used to treat anaphylactic shock, asthma, hemorrhage, and ventricular fi brillation. The nonselective activity stimulates all four adrenergic subtypes. • Dopamine, a vasopressor, is used to correct the hemodynamic imbalances present in shock. Dopamine is a naturally occurring catecholamine and a precursor to norepinephrine. It stimulates alpha and beta receptors directly and indirectly (by releasing the stored epinephrine). It also has dopaminergic effects, including increased renal perfusion, increased cardiac output, increased or decreased peripheral resistance (depending on the dose), and increased blood pressure. • Drugs that are relatively selective for beta-2 stimulation are used to treat asthma. • Fenoldopam, a dopamine-1 agonist, is used in the management of acute hypertension for rapid reduction of blood pressure. • Alpha-1 antagonists, such as prazosin, cause vasodilation and are used to treat hypertension and benign prostatic hyperplasia (BPH). • Beta-blockers, such as metoprolol, are relatively selective for beta-1 receptors in the heart; in larger doses they also have effects on beta-2 receptors. They are used to treat hypertension, angina, controlled chronic heart failure, cardiac arrhythmias, hyperthyroidism, and migraine headache.

AB - • Regulation of physiologic processes in the autonomic nervous system (ANS) is managed by oppositional or complementary stimulation by the sympathetic (adrenergic) and parasympathetic (cholinergic) nervous systems. • To effect an action, a neurotransmitter needs to bind with an appropriate receptor site on the effector organ or tissue. • The primary neurotransmitter of the sympathetic nervous system (SNS) is norepinephrine (NE). Additionally, epinephrine and dopamine stimulate adrenergic receptors. • The SNS, commonly referred to as the fi ght-or-fl ight system, increases cardiovascular and respiratory function, increases metabolism, diverts blood to muscles, and decreases GI activity. • SNS receptors with pharmacological relevance are subdivided into alpha-1, alpha-2, beta-1, and beta-2 subtypes. Alpha-1, beta-1, and beta-2 receptors are located on the post-synaptic side of the synapse, while alpha-2 receptors are located on the pre-synaptic side of the synapse. Stimulation of alpha-2 receptors acts as a negative feedback and shuts off the fl ow of NE, stopping sympathetic stimulation. • Adrenergic agonists stimulate the adrenergic receptors, whereas adrenergic antagonists block adrenergic receptors within the SNS, preventing endogenous neurotransmitters from attaching to the receptor. There are multiple terms for these categories of drugs. • Alpha-1 agonists, such as phenylephrine, stimulate alpha-1 receptors directly. They are most commonly used as nasal decongestants and in ophthalmology to achieve mydriasis. They may also be used as vasopressors to treat vascular failure and related shock. • Alpha-2 agonists such as clonidine shut off the sympathetic release of NE and sympathetic stimulation. They are used in the treatment of substance abuse to prevent withdrawal symptoms and have a minor use in the treatment of hypertension. • Nonselective adrenergic agonists, such as epinephrine, are used to treat anaphylactic shock, asthma, hemorrhage, and ventricular fi brillation. The nonselective activity stimulates all four adrenergic subtypes. • Dopamine, a vasopressor, is used to correct the hemodynamic imbalances present in shock. Dopamine is a naturally occurring catecholamine and a precursor to norepinephrine. It stimulates alpha and beta receptors directly and indirectly (by releasing the stored epinephrine). It also has dopaminergic effects, including increased renal perfusion, increased cardiac output, increased or decreased peripheral resistance (depending on the dose), and increased blood pressure. • Drugs that are relatively selective for beta-2 stimulation are used to treat asthma. • Fenoldopam, a dopamine-1 agonist, is used in the management of acute hypertension for rapid reduction of blood pressure. • Alpha-1 antagonists, such as prazosin, cause vasodilation and are used to treat hypertension and benign prostatic hyperplasia (BPH). • Beta-blockers, such as metoprolol, are relatively selective for beta-1 receptors in the heart; in larger doses they also have effects on beta-2 receptors. They are used to treat hypertension, angina, controlled chronic heart failure, cardiac arrhythmias, hyperthyroidism, and migraine headache.

UR - http://www.scopus.com/inward/record.url?scp=84971276089&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84971276089&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:84971276089

SN - 9781451187663

SP - 161

EP - 194

BT - Drug Therapy in Nursing

PB - Wolters Kluwer Health Adis (ESP)

ER -